Lunaphore: Funding, Investors & Team (Sep 2026)
Lunaphore provides remedies that are dependent on a chip technology that has the capability of capturing proteomic and transcriptome data from tumors and various other tissues. This chip technology can effectively convert any assay into multiplex spatial biology with a user-friendly interface. It lets immune system, cancer immunology, and neurology researchers to expand their knowledge on scientific breakthroughs and the development of therapeutic solutions. The technology used by Lunaphore detects certain biomarker "signatures" that can be beneficial in developing diagnostic tools and simplifying clinical trials, which ultimately results in better patient outcomes.
Lunaphore has raised $32.8M across 1 funding round on record, the most recent a Series D of $32.8M announced in Mar 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Lunaphore Company Profile and Key Stats
Latest funding round on record: Mar 2023.
Lunaphore Funding Rounds
Lunaphore Founders and Leadership Team
No contact details are on record for this team yet.
Lunaphore Funding Compared to Other Biotechnology Startups
Lunaphore's latest round of $32.8M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Lunaphore in Biotechnology and Lausanne
Companies Similar to Lunaphore
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
At Immitra Bio, we are developing a unique genetic medicine platform that combines two of the most powerful…
compliag is providing agile solutions for regulated industries, including the licencing, manufacturing and…
MoonLake Immunotherapeutics is a biopharmaceutical company in the clinical stage that is developing new…
Isospec Analytics SA is a life science company that aims at simplifying molecular identification. We are…
Cria Technologies reinvents cold-chain transport with high-vacuum insulation technology that offers…
Precise Health is a phage therapy platform that specialises in improving and treating bacterial infections to…
AC Immune is a biopharmaceutical company based in Switzerland that is currently in the clinical stage. They…
AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at…
Combioxin SA is clinical-stage biotech company developing innovative anti-virulence drugs to treat severe…
MindMaze is a digital neurotherapeutic platform that provides digital assessments and therapeutics to treat…
Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the…
Lunaphore Funding FAQs
What does Lunaphore do?
Lunaphore provides remedies that are dependent on a chip technology that has the capability of capturing proteomic and transcriptome data from tumors and various other tissues. This chip technology can effectively convert any assay into multiplex spatial biology with a user-friendly interface. It lets immune system, cancer immunology, and neurology researchers to expand their knowledge on scientific breakthroughs and the development of therapeutic solutions. The technology used by Lunaphore detects certain biomarker "signatures" that can be beneficial in developing diagnostic tools and simplifying clinical trials, which ultimately results in better patient outcomes.
How much funding has Lunaphore raised?
Lunaphore has raised $32.8M across 1 round on record. The most recent is a Series D of $32.8M announced in Mar 2023.
When did Lunaphore last raise funding?
Lunaphore's most recent funding round on record is a Series D of $32.8M, announced in Mar 2023.
Who founded Lunaphore?
FundedIQ lists Deborah Heintze (Founder) at Lunaphore.
Where is Lunaphore headquartered?
Lunaphore is based in Lausanne, Vaud, Switzerland.
How many employees does Lunaphore have?
Lunaphore is in the 101-250 employee band.
How does Lunaphore's funding compare to other Biotechnology startups?
Lunaphore's latest round of $32.8M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Lunaphore Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Lunaphore is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.